October 21, 2010 – For the first time, a hospital in the United Kingdom will offer women osteoporosis detection and mammography in a single exam. Sectra reached an agreement with Aspen Healthcare to use Sectra’s screening tools at the Holly House Hospital.

The initiative could also drastically reduce care costs, since fractures caused by osteoporosis will decline.

“For most women, regular mammography examinations are a natural part of the safety net for early detection of breast cancer. The ability to conduct screening to identify osteoporosis at the same time could mean that many women will avoid unnecessary suffering and could result in major cost-savings for society,” said Torbjörn Kronander, president of Sectra’s medical operations.

Based on a single radiology image of the hand, taken in connection with the mammography examination and using the same equipment, the Sectra dxr-online service calculates bone mineral density. To perform the combined examination, Holly House has invested in Sectra MicroDose Mammography, which with superior image quality, generates the lowest radiation dose available. Sectra MicroDose Mammography is currently awaiting approval from the U.S. Food and Drug Administration (FDA).

“We are extremely excited to be using these exceptional technologies for our mammography and osteoporosis services. The dxr-online service has enabled us to safely monitor patients’ bone mineral density on a regular basis providing early indication of the risk of developing osteoporosis and therefore giving the patient the opportunity for a better quality of life,” said Allyson Budino, manager of the diagnostic centre at Holly House Hospital.

Osteoporosis-related fractures remain one of the major health threats for women. But if women in the risk zone for osteoporosis are identified at an early stage, there are now inexpensive and effective ways of preventing fractures through lifestyle changes and medication.

For more information: www.sectra.com


Related Content

News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Digital Pathology

Feb. 11, 2026 — Leica Biosystems has announced the global launch of the Leica CM1950 Cryostat with DualEcoTec Cooling ...

Time February 11, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | FDA

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...

Time February 02, 2026
arrow
News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
Subscribe Now